- Karmastock
- uploaded: Feb 6, 2012
- Hits: 109
Description:
BioLineRx Ltd BLRX - reported that it has signed a worldwide, exclusive license agreement with Genoscience and RFS Pharma to develop and commercialize BL-8030, an orally available treatment for Hepatitis C.
Tags:
Categories:
0 comments
No comments yet.











